Skip to main content

Table 4 Infused volumes and fluid balance according to the Glasgow Outcome Score (GOS)

From: Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension

 

GOS after 3 months

GOS after 6 months

GOS after 12 months

GOS 1–3

GOS 4–5

GOS 1–3

GOS 4–5

GOS 1–3

GOS 4–5

Fluid balance, median (IQ)

 Cumulative (day, ml)

−223 ((−600)−22)

−806 ((−1228)–(−324))

−215 ((−585)−39)

−806 ((−1216)–(−332))

− 214 ((−582)−54)

−770 ((−1202)–(−328))

 Within the first 7 days (l)

−0.7 ((−3.0)−1.2)

−5.6 ((−8.5)–(−1.7))

−0.6 ((−2.8)−1.3)

−5.8 ((−8.3)–(−1.8))

−0.6 ((−2.8)−1.2)

−5.7 ((−8.1)–(−1.6))

 Cumulative in the ICU (l)

−5.9 ((−13.0)−0.5)

−8.7 ((−14.0)–(−2.2))

−5.3 ((−12.6)−0.5)

−8.7 ((−14.3)–(−2.4))*

−5.2 ((−12.4)−0.5)

−8.7 ((−14.4)–(−2.3))*

Colloids

 n (%)

54 (65.1)

32 (54.2)

50 (64.9)

36 (55.4)

47 (63.5)

39 (57.4)

 Total (l), median (IQ)

4.0 (1.5–8.1)

3.8 (2.0–6.7)

4.0 (1.9–8.1)

3.5 (1.6–6.7)

4.0 (1.5–8.0)

4.0 (2.0–7.5)

 Total (kg BW, ml), median (IQ)

51 (21–99)

44 (25–107)

51 (22–99)

44 (22–107)

42 (21–94)

53 (25–116)

Diuretics, n (%)

      

 Any

55 (66.3)

19 (32.2)

53 (66.8)

21 (32.3)

50 (67.6)

24 (35.3)

 Furosemide/bolus (10–20 mg)

47 (65.6)

16 (27.1)

45 (58.4)

18 (27.7)

42 (56.8)

21 (30.9)

 Furosemide/perfusion (2–5 mg/h)

16 (19.3)

3 (5.1)*

15 (19.5)

4 (6.2)*

13 (17.6)

6 (8.8)

 Others

21 (25.3)

6 (10.2)*

21 (27.5)

6 (9.2)

21 (28.4)

6 (8.8)

CVP (mmHg), median (IQ)

 Within 24 h

6 (4–7.9)

6 (5–8.4)

6 (4–8.3)

6 (5–8.1)

6 (4–8.3)

6 (5–8.1)

 Within 7 days

7 (5.5–7.8)

5 (4.3–6.3)

7 (5.5–7.9)

5 (4.3–6.4)

7 (5.5–8)

5 (4.5–6.5)

  1. CVP central venous pressure
  2. p 0.05–0.01;  p < 0.001;  p < 0.001